NCT05003986Phase 2Recruiting

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Study sponsor: Travere Therapeutics, Inc. · TVTX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-03-12Estimated
Enrollment · participants67Estimated
Source updated2026-05-12Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview